summary

Here is a passage from the RYBREVANT PATIENT INFORMATION which may be helpful to address your question:

How will I receive RYBREVANT?

• RYBREVANT will be given to you by your healthcare provider by intravenous infusion into your vein.¹
• Your healthcare provider will decide the time between doses as well as how many treatments you will receive.¹
• Your healthcare provider will give you medicines before each dose of RYBREVANT to help reduce the risk of infusion-related reactions.¹
• RYBREVANT may be given in combination with the medicines carboplatin and pemetrexed. If you have any questions about these medicines, ask your healthcare provider.¹
• If your treatment with RYBREVANT is given in combination with the medicine lazertinib, you should take your lazertinib dose by mouth anytime before your infusion with RYBREVANT.¹
• If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment.¹

PRODUCT LABELING

• RYBREVANT (amivantamab-vmjw) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.; http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/RYBREVANT-pi.pdf.
• LAZCLUZE (lazertinib) [Prescribing Information]. Horsham, PA: Janssen Biotech, Inc.; http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/LAZCLUZE-pi.pdf.

ADDITIONAL INFORMATION

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest using it in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the PATIENT INFORMATION for RYBREVANT.¹